RxDoctor Payments Data

Gangadhar Sreepada, MD

Otolaryngology/Facial Plastic Surgery · Wayne, NJNPI 1801842893

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.2% of the total across 217 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 20.8% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,189, 5.1 times the $232 reported in 2019.

$4,072in general payments, 2019–2025

Across 217 payments — averaging $18.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sanofi$848
  • Aerin Medical Inc.$678
  • GSK$480
  • Optinose US, Inc.$375
  • Regeneron Healthcare Solutions, Inc.$371
  • CSL Behring$229
  • plus $1K from 24 others

What the payments were for

  • Food & beverage$4,03899%
  • Education$341%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,072 in reported general payments places this provider in the 80th percentile of 36 otolaryngology/facial plastic surgery providers in New Jersey.

See all otolaryngology/facial plastic surgery providers in New Jersey

Medicare billing

Part B allowed, 2024
$509,446
Medicare patients
1,067
Services billed
5,854

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Azelastine-FluticasoneAzelastine/Fluticasone47$6,839
Fluticasone Propionate347$5,970
Azelastine Hcl161$4,788
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth29$4,334
Fluocinolone Acetonide Oil98$3,923
Ipratropium Bromide84$2,826
Mometasone Furoate12$932
Prednisone393$798
Montelukast Sodium38$763
Azithromycin157$745
CefuroximeCefuroxime Axetil49$712
Doxycycline Hyclate27$282
Mupirocin60$282
Levocetirizine Dihydrochloride15$267
Acetic Acid13$162

Paid to pharmacies, not to this prescriber.

Other otolaryngology/facial plastic surgery in Wayne

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →